Core Insights - KNOREX Ltd. has announced a strategic partnership with a premier B2B data provider to enhance its AI-driven digital advertising capabilities, enabling marketers to execute smarter and more precise campaigns at scale [1][4]. Company Overview - KNOREX Ltd. is a B2B technology company founded in 2009, specializing in AI-driven cross-channel programmatic advertising solutions [5]. - The company's flagship platform, KNOREX XPO, is a cloud-based advertising technology that facilitates efficient planning, execution, and optimization of digital ad campaigns across various media [5][6]. Partnership Details - The collaboration integrates KNOREX's advanced AI with the partner's human-verified proprietary B2B dataset, providing customers with high-quality data for targeted marketing [3][4]. - This partnership aims to empower sales and marketing teams with actionable insights, accelerating customer acquisition and revenue growth [2][3]. Market Positioning - The integration of proprietary data into KNOREX XPO is expected to enhance campaign performance, reduce wasted ad spend, and improve efficiency in marketing efforts [6]. - KNOREX serves a diverse range of industries, including technology, financial services, and healthcare, positioning itself as a leader in the evolving digital advertising landscape [2][7].

Core Insights - KNOREX Ltd. has successfully listed on the NYSE American, marking a significant milestone in its journey and providing vital capital for global growth [1] - The company aims to lead the future of AI-powered online advertising orchestration and automation, addressing challenges such as fragmentation and orchestration complexities in the digital advertising landscape [2] Financial Performance - In 2024, KNOREX generated $10.8 million in revenue, a 24.0% increase from $8.7 million in 2023 [3] - Gross profit rose by 40.0%, from $3.2 million in 2023 to $4.5 million in 2024 [3] - The global digital advertising market is projected to reach $871 billion by 2027, positioning KNOREX to capture a larger market share [3] Business Strategy - The capital raised from the IPO will accelerate KNOREX's growth strategy, focusing on AI-driven solutions and geographic expansion in North America and Asia [4] - The company's proprietary machine learning and automation capabilities enable predictive budgeting, attribution, and real-time optimization across channels [4] - KNOREX is committed to building a sustainable and profitable business model to serve the rapidly transforming advertising industry [4][5] Market Position - KNOREX XPO, the company's flagship platform, centralizes campaign execution and analytics, enhancing efficiency and transparency for advertisers [7] - The platform supports a wide range of digital media formats, including social media, search, CTV/OTT, video, audio, display, native, and digital-out-of-home advertising [6][7] - KNOREX serves global enterprises, agencies, and brands, helping them navigate the complexities of online advertising with intelligent, data-driven solutions [8]

Company Overview - Knorex Ltd. is a B2B technology company founded in 2009, specializing in AI-driven marketing automation and digital advertising solutions [6] - The company's flagship platform, Knorex XPO, is an AI-powered, cloud-based advertising technology platform that enables efficient planning, execution, and optimization of cross-channel ad campaigns [6][7] - Knorex serves global enterprises, agencies, and brands across various industries, with operations in the United States, Vietnam, India, Malaysia, and Singapore [8] Initial Public Offering (IPO) Details - Knorex announced the closing of its IPO, offering 3,000,000 Class A ordinary shares at a public offering price of $4.00 per share, resulting in gross proceeds of $12.0 million before deductions [1] - The IPO was conducted on a firm commitment basis, with R. F. Lafferty & Co. Inc. as the lead book-running manager and Craft Capital Management LLC as co-manager [3] - The company has granted underwriters a 45-day option to purchase an additional 450,000 Class A ordinary shares, representing 15% of the shares sold in the offering [2] Trading Information - The Class A ordinary shares of Knorex began trading on the NYSE American under the symbol "KNRX" on September 29, 2025 [2][4]